Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

13
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
13
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.0K
The pathophysiology of pneumonia involves the following steps:
4.0K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive Factors for Mediastinal Lymph Node Metastases in Patients with Non-small Cell Lung Cancer, as Detected by Video-assisted Mediastinoscopic Lymphadenectomy.

Zentralblatt fur Chirurgieยท2026
Same author

Diagnostic discordance and differential diagnoses of community-acquired pneumonia in the emergency department.

BMC emergency medicineยท2026
Same author

Hermansky-Pudlak Syndrome Type 1 with pulmonary fibrosis: A case report and re-view of management.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizinยท2026
Same author

Management of Adult Bronchiectasis: Consensus-Based Guidelines of the German Respiratory Society.

Respiration; international review of thoracic diseasesยท2026
Same author

Pandemic revisited: Characteristics, severity and clinical outcomes of patients hospitalized with SARS-CoV-2-infection in different periods of the pandemic.

Pneumologie (Stuttgart, Germany)ยท2025
Same author

[Recommendations for vaccination of adults for respiratory physicians].

Pneumologie (Stuttgart, Germany)ยท2025

Related Experiment Video

Updated: Mar 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

[Community-acquired pneumonia].

Joachim Lorenz, Santiago Ewig

    Deutsche Medizinische Wochenschrift (1946)
    |April 1, 2016
    PubMed
    Summary

    Community acquired pneumonia (CAP) involves a narrow range of pathogens. Current treatment algorithms focus on CAP, discarding the healthcare-associated pneumonia (HCAP) concept due to its limited predictive value for resistant pathogens.

    Area of Science:

    • Infectious Diseases
    • Pulmonology
    • Microbiology

    Context:

    • Community acquired pneumonia (CAP) presents a distinct etiological profile compared to hospital-acquired infections.
    • The traditional distinction between CAP and healthcare-associated pneumonia (HCAP) is being re-evaluated.
    • HCAP classification has shown limited utility in predicting the likelihood of multidrug-resistant (MDR) pathogens.

    Purpose:

    • To reassess the diagnostic and treatment paradigms for pneumonia.
    • To refine pneumonia classification systems for improved patient management.
    • To determine the clinical relevance of the HCAP concept in contemporary infectious disease practice.

    Summary:

    • Community acquired pneumonia (CAP) is characterized by a relatively limited spectrum of causative pathogens.

    More Related Videos

    Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
    15:43

    Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

    Published on: March 17, 2014

    24.1K
    Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
    07:39

    Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

    Published on: April 6, 2021

    4.3K

    Related Experiment Videos

    Last Updated: Mar 23, 2026

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
    11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    15.7K
    Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
    15:43

    Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

    Published on: March 17, 2014

    24.1K
    Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
    07:39

    Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

    Published on: April 6, 2021

    4.3K
  • The concept of healthcare-associated pneumonia (HCAP) is being discarded as it does not reliably predict the presence of multidrug-resistant organisms.
  • Treatment algorithms are shifting to focus primarily on CAP, with distinct approaches for hospital-acquired or immunoincompetent-related pneumonias.

    • Impact:

    • This shift simplifies pneumonia classification and management strategies.
    • It encourages a more targeted approach to diagnosing and treating pneumonia based on likely pathogens.
    • Improved patient outcomes are anticipated through more accurate risk stratification and antimicrobial stewardship.